{"id":"W2074007950","doi":"10.1038/ajg.2013.441","title":"Drug Therapies and the Risk of Malignancy in Crohn's Disease: Results From the TREAT™ Registry","year":2014,"lang":"en","type":"article","venue":"The American Journal of Gastroenterology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":171,"is_retracted":false,"has_abstract":true,"ca_institutions":"Western University; Robarts Clinical Trials","funders":"Janssen Biotech","keywords":"Medicine; Internal medicine; Hazard ratio; Crohn's disease; Infliximab; Malignancy; Incidence (geometry); Population; Cancer registry; Discontinuation; Proportional hazards model; Cohort; Inflammatory bowel disease; Disease; Cancer; Confidence interval","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002285506,0.0001281475,0.0003695542,0.0009377599,0.0001654921,0.000668066,0.0003208038,0.0002688771,0.0006539801],"category_scores_gemma":[0.006931712,0.0001493691,0.0005315327,0.00199023,0.0001588507,0.0004817277,0.0005539794,0.0003848691,0.000227269],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002665742,"about_ca_system_score_gemma":0.0004833837,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002903949,"about_ca_topic_score_gemma":0.004564099,"domain_scores_codex":[0.997903,0.0007860841,0.0003836338,0.0003299664,0.0004593026,0.000138036],"domain_scores_gemma":[0.9913394,0.001905082,0.005124555,0.0005863308,0.0006707842,0.0003739267],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0001330346,0.00001216182,0.9982475,0.0000170419,0.00005115892,0.00001543781,0.00002041522,0.00004246465,0.00003575122,0.00000901031,0.0001413499,0.0012747],"study_design_scores_gemma":[0.00001733606,0.00006636878,0.9990425,0.00001227568,0.0000715225,0.0001216444,0.00004735434,0.0001330818,0.00006177007,0.000007805725,0.0004153021,0.000002981346],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9936912,0.00111364,0.0001741484,0.0001050288,0.00000884687,0.00001564091,0.004297392,0.00001104896,0.0005830513],"genre_scores_gemma":[0.9938187,0.0007149893,0.0002786627,0.00004008946,0.00002838239,0.00002142287,0.004937816,0.000004988365,0.0001549982],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002903949,"threshold_uncertainty_score":0.01208711,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.003075984081980354,"score_gpt":0.2033876395282829,"score_spread":0.2003116554463026,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}